Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass and Visceral Fat Accumulation
Yansu Wang,Yiting Xu,Tingting Hu,Yunfeng Xiao,Yufei Wang,Xiaojing Ma,Haoyong Yu,Yuqian Bao
DOI: https://doi.org/10.2147/dmso.s444142
2024-01-09
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yansu Wang, 1, &ast Yiting Xu, 1, &ast Tingting Hu, 1 Yunfeng Xiao, 2 Yufei Wang, 1 Xiaojing Ma, 1 Haoyong Yu, 1 Yuqian Bao 1 1 Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, People's Republic of China; 2 Department of Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuqian Bao, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai, 200233, People's Republic of China, Tel +86-21-64369181, Fax +86-21-64368031, Email Background: It has been reported recently that the ratio of uric acid to high-density lipoprotein cholesterol (UHR) is correlated with several metabolic disorders. The present study aimed to investigate the associations of UHR with body fat content and distribution. Methods: This study enrolled 300 participants (58 men and 242 women) aged 18 to 65 years. The levels of serum uric acid and high-density lipoprotein cholesterol were measured by standard enzymatic methods. The overall fat content and segmental fat distribution were assessed with an automatic bioelectrical impedance analyzer. In the population with obesity, the visceral fat area (VFA) and subcutaneous fat area (SFA) were measured using magnetic resonance imaging. Results: Among the study population, 219 individuals (73.0%) were with obesity. The median level of UHR in individuals with obesity was 33.7% (26.2% - 45.9%), which was significantly higher than that in those without obesity [22.6% (17.0% - 34.4%), P < 0.01]. UHR was positively associated with overall fat content and segmental fat distribution parameters (all P < 0.01). In multivariate linear regression analysis, compared with body mass index, waist circumference was more closely associated with UHR (standardized β = 0.427, P < 0.001) after adjusting for confounding factors. Additionally, total fat mass (standardized β = 0.225, P = 0.002) and trunk fat mass (standardized β = 0.296, P = 0.036) were more closely linked to UHR than total fat-free mass and leg fat mass, respectively. In the population with obesity, VFA was independently correlated with UHR ( P < 0.01), while SFA was not associated with UHR. Conclusion: UHR was significantly associated with overall fat content and trunk fat accumulation. In the population with obesity, UHR was positively associated with VFA. Attention should be paid to the role of excessive trunk fat mass in the relationship between UHR and metabolic disorders. Keywords: fat distribution, the UHR index, trunk fat mass, visceral fat area Obesity is currently recognized as one of the major public health issues in the world, which has a great impact on human health and imposes a substantial cost on social and economic development. Accumulating evidence has established close relationships between obesity and a variety of metabolic disorders and cardiovascular diseases. According to the most recent epidemiologic data, the overweight and obesity rates in the Chinese adult population were 34.3% and 16.4%, respectively. 1 Therefore, it is crucial to strengthen the control of obesity and its associated comorbidities. Elevated uric acid (UA) levels and decreased high-density lipoprotein cholesterol (HDL-c) levels are two common metabolic abnormalities associated with obesity. UA is a weak organic acid generated from xanthine by xanthine-oxidase. It is the ultimate breakdown product of purine nucleotides in circulation. UA is generated mainly in the liver and small intestine and eliminated by the kidney and intestine. When the body's purine metabolism is disrupted, or UA excretion is irregular, serum UA levels are increased. Gout can occur if the quantity of UA in the bloodstream surpasses its saturation point. 2 Numerous studies provide evidence that hyperuricemia and gout are independent risk factors for several disorders, including chronic renal disease, hypertension, type 2 diabetes, and cardiovascular diseases. 3,4 In recent years, some clinical studies have demonstrated an association between increased serum UA levels and aberrant body fat distribution, especially abdominal fat accumulation. 5,6 HDL-c is an essential serum lipoprotein that t -Abstract Truncated-
endocrinology & metabolism